A word of caution on MEDX, if I may...this seems to hvve popped this newscast and on anecdotal data regarding a single patient.
With biotechs, imo, such pops are seldom sustainable.
Sure, the video looks good news for those afflicted with this cancer,
but from an investing perspective, the fact that the study is still recruiting patient as of August 2007, tells me it is a ways from being done and from releasing data.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.